| Dr Souheil H Khoukaz, MD | |
|
1390 Highway 61 South, Suite 3300, Festus, MO 63028 | |
| (636) 933-5055 | |
| Not Available |
| Full Name | Dr Souheil H Khoukaz |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 34 Years |
| Location | 1390 Highway 61 South, Festus, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386636868 | NPI | - | NPPES |
| 1386636868 | Medicaid | MO |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 118388 (Missouri) | Primary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 118388 (Missouri) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Hospital Jefferson | Festus, MO | Hospital |
| Washington County Memorial Hospital | Potosi, MO | Hospital |
| Perry County Memorial Hospital | Perryville, MO | Hospital |
| Parkland Health Center | Farmington, MO | Hospital |
| Madison Medical Center | Fredericktown, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mercy Clinic Heart And Vascular Llc | 8820016207 | 91 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies.
› Verified 8 days ago
| Entity Name | Mercy Clinic Heart And Vascular Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932176401 PECOS PAC ID: 8820016207 Enrollment ID: O20051103000947 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies.
› Verified 8 days ago
| Entity Name | Mercy Hospital Perry |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1063117158 PECOS PAC ID: 1153777826 Enrollment ID: O20231101001515 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Souheil H Khoukaz, MD 12855 N 40 Dr, Suite 300, Saint Louis, MO 63141-8657 Ph: (314) 880-6162 | Dr Souheil H Khoukaz, MD 1390 Highway 61 South, Suite 3300, Festus, MO 63028 Ph: (636) 933-5055 |
News Archive
Researchers in the United States have conducted a study showing that Moderna's coronavirus disease 2019 (COVID-19) vaccine provided durable protection against the B.1.617.2 (delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in rhesus macaques.
Merck on Tuesday agreed to a $58 million settlement with 29 states and the District of Columbia to end investigations over allegations that it downplayed cardiovascular risks caused by the COX-2 inhibitor Vioxx in direct-to-consumer advertisements dating back to 1999, the AP/Philadelphia Inquirer reports (Raffaele, AP/Philadelphia Inquirer, 5/21).
A new study reports on a set of antibodies from COVID-19 donor serum, which seems to be cross-reactive across multiple Sarbecoviruses, including the very similar SARS-CoV-2, SARS-CoV and Middle East Respiratory Syndrome (MERS)-CoV.
California officials worry that highly publicized problems of the federal website will scare customers away from the state marketplace, which is open for business. Meanwhile, news outlets look at issues in New York, Connecticut, Texas and Minnesota.
Svelte Medical Systems, Inc. is pleased to announce that it has successfully completed the extension of its Series A financing from institutional and private investors including CNF Investments, Apjohn Ventures and the Fischell family. The company's Series A extension was oversubscribed and included an initial investment by Norwich Ventures LP. Norwich Ventures is a seed and early-stage venture capital firm committed to helping entrepreneurs, healthcare professionals and inventors build innovative medical technology companies.
› Verified 8 days ago
Holly Ackermann, FNP Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1153 E Gannon Dr, Festus, MO 63028 Phone: 636-282-0380 Fax: 636-282-0384 | |
Karthik Iyer, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Us Highway 61, Festus, MO 63028 Phone: 636-933-5337 | |
Joanne M Waltman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1500 Calvary Church Rd, Festus, MO 63028 Phone: 636-933-2900 Fax: 636-933-8017 | |
Dr. Manzoor Ahmad Tariq, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1071 Airport Road, Festus, MO 63028 Phone: 636-931-7111 Fax: 636-937-7486 | |
Amit J Shah, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 1500 Calvary Church Rd, Festus, MO 63028 Phone: 636-933-2900 | |
Amanda E Avellone, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1390 Highway 61, Ste 2300, Festus, MO 63028 Phone: 636-937-3121 Fax: 636-937-4423 | |
Dr. Edwardo Durante Verzola, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 1400 Us Highway 61, Suite 250, Festus, MO 63028 Phone: 636-937-8675 Fax: 636-933-7981 |